Alexander Gerhard

Alexander Gerhard is a Preclinical Project Manager at 3B Pharmaceuticals GmbH since May 2025, focusing on bridging discovery to First in Human. Prior to this, Alexander served as a Scientist and Study Director in Toxicology at Nuvisan ICB GmbH from June 2021 to May 2025, where responsibilities included leading GLP studies and establishing a competent GLP test facility while emphasizing animal welfare. Alexander's academic background includes a Ph.D. in Biomedical Sciences from Freie Universität Berlin, alongside a veterinary license and specialization in pharmacology and toxicology. Research experience encompasses roles as a Research Scientist and Research Associate, with notable achievements in developing a genetic model for drug resistance and managing international research collaborations.